BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28329519)

  • 1. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold.
    Craddock LN; Cooley DM; Endo JO; Longley BJ; Caldera F
    Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
    Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-induced alopecia: alternative pathology and therapy.
    Udkoff J; Cohen PR
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
    Zamperetti M; Zelger B; Höpfl R
    Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab-related alopecia in a patient affected by psoriasis.
    Melé-Ninot G; Expósito-Serrano V; Quintana Codina M; Iglesias Sancho M; Sánchez-Regaña M; Umbert Millet P; Salleras Redonnet M
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab-induced scalp psoriasis with severe alopecia.
    Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
    Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.
    Ostojic P; Pavlov-Dolijanovic S
    Z Rheumatol; 2018 Jun; 77(5):412-415. PubMed ID: 29744570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
    Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
    Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia secondary to anti-tumor necrosis factor-alpha therapy.
    Ribeiro LB; Rego JC; Estrada BD; Bastos PR; Piñeiro Maceira JM; Sodré CT
    An Bras Dermatol; 2015; 90(2):232-5. PubMed ID: 25830994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy.
    Afanasiev OK; Zhang CZ; Ruhoy SM
    J Cutan Pathol; 2017 Jun; 44(6):563-569. PubMed ID: 28332233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia universalis during treatment with leflunomide and adalimumab - case report.
    Lazzarini R; Capareli GC; Buense R; Lellis RF
    An Bras Dermatol; 2014; 89(2):320-2. PubMed ID: 24770511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors.
    Carrasquillo OY; Pabón-Cartagena G; Barrera-Llaurador J; Colón-Fontanez F; Martín-García RF
    Cutis; 2021 Apr; 107(4):E48-E55. PubMed ID: 34096864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR; Liebman TN; Alapati U; Khachemoune A
    Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
    Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
    Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha antagonist induced lupus on three different agents.
    Mudduluru BM; Shah S; Shamah S; Swaminath A
    Postgrad Med; 2017 Mar; 129(2):304-306. PubMed ID: 27748629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced psoriasiform alopecia associated with interleukin-17 inhibitor therapy.
    Tan TL; Taglia L; Yazdan P
    J Cutan Pathol; 2021 Jun; 48(6):771-774. PubMed ID: 33389767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab.
    Koumaki D; Koumaki V; Katoulis A; Lagoudaki E; Boumpoucheropoulos S; Stefanidou M; Miaris O; Baltaga L; Evangelou G; Zografaki K; Krueger-Krasagakis SE; Krasagakis K
    Dermatol Ther; 2020 Jul; 33(4):e13791. PubMed ID: 32510744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.